Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 7 studies | 25% ± 12% | |
| endothelial cell | 4 studies | 27% ± 10% | |
| interneuron | 4 studies | 32% ± 19% | |
| neuron | 3 studies | 25% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 25% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 6490.24 | 21 / 21 | 100% | 40.01 | 504 / 504 |
| brain | 100% | 15552.99 | 2642 / 2642 | 100% | 143.39 | 705 / 705 |
| breast | 100% | 5970.98 | 459 / 459 | 100% | 72.16 | 1118 / 1118 |
| prostate | 100% | 6678.71 | 245 / 245 | 100% | 51.65 | 502 / 502 |
| thymus | 100% | 6233.43 | 653 / 653 | 100% | 58.05 | 604 / 605 |
| uterus | 100% | 9197.18 | 170 / 170 | 100% | 46.28 | 458 / 459 |
| skin | 100% | 5037.89 | 1803 / 1809 | 100% | 73.50 | 472 / 472 |
| intestine | 100% | 5697.46 | 964 / 966 | 99% | 31.94 | 524 / 527 |
| esophagus | 100% | 5427.70 | 1441 / 1445 | 99% | 47.03 | 182 / 183 |
| ovary | 100% | 9709.82 | 180 / 180 | 99% | 39.50 | 426 / 430 |
| lung | 99% | 5258.67 | 574 / 578 | 100% | 43.95 | 1152 / 1155 |
| adrenal gland | 100% | 7353.79 | 257 / 258 | 98% | 54.75 | 226 / 230 |
| kidney | 100% | 4795.91 | 89 / 89 | 98% | 50.71 | 881 / 901 |
| stomach | 97% | 3825.25 | 348 / 359 | 99% | 34.64 | 284 / 286 |
| pancreas | 94% | 2532.64 | 308 / 328 | 99% | 41.63 | 176 / 178 |
| liver | 88% | 1983.67 | 199 / 226 | 93% | 23.95 | 376 / 406 |
| adipose | 100% | 5639.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 54.66 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 35.90 | 29 / 29 |
| muscle | 100% | 9413.83 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 6598.54 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 35.37 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 31.45 | 1 / 1 |
| blood vessel | 100% | 6707.15 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 4322.74 | 845 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 59% | 2046.97 | 551 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_2000786 | Biological process | positive regulation of autophagosome assembly |
| GO_0061909 | Biological process | autophagosome-lysosome fusion |
| GO_1902635 | Biological process | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process |
| GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
| GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
| GO_0010506 | Biological process | regulation of autophagy |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005776 | Cellular component | autophagosome |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0016308 | Molecular function | 1-phosphatidylinositol-4-phosphate 5-kinase activity |
| GO_0016309 | Molecular function | 1-phosphatidylinositol-5-phosphate 4-kinase activity |
| GO_0005525 | Molecular function | GTP binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PIP4K2B |
| Protein name | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II beta) (PIP4KII-beta) (PtdIns(5)P-4-kinase isoform 2-beta) |
| Synonyms | PIP5K2B |
| Description | FUNCTION: Participates in the biosynthesis of phosphatidylinositol 4,5-bisphosphate . Preferentially utilizes GTP, rather than ATP, for PI(5)P phosphorylation and its activity reflects changes in direct proportion to the physiological GTP concentration . Its GTP-sensing activity is critical for metabolic adaptation . PIP4Ks negatively regulate insulin signaling through a catalytic-independent mechanism. They interact with PIP5Ks and suppress PIP5K-mediated PtdIns(4,5)P2 synthesis and insulin-dependent conversion to PtdIns(3,4,5)P3 . . |
| Accessions | P78356 ENST00000631946.1 ENST00000613180.2 [P78356-1] ENST00000619039.5 [P78356-1] A0A087WT35 ENST00000617499.1 |